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1. Introduction 
Oogenesis in Xenopus laevis, the South African 
clawed frog, proceeds as a continuous asynchronous 
process; therefore oocytes in all stages of develop- 
ment are simultaneously present in the ovary of the 
adult frog [ 11. Mature Xenopus oocytes provide a 
convenient heterologous system for the translation of 
a variety of microinjected mRNAs [2--4]; when 
mRNAs for secretory proteins are employed, com- 
partmentalization and secretion of these proteins also 
occur [ 51. Xenopus oocytes therefore serve as an 
experimental system for the investigation of secretory 
processes [6], and the cumulative yield of secreted 
proteins directed by microinjected mRNAs provides 
a measure to estimate the half-life of their corre- 
sponding mRNAs [5,7,8]. Proteolytic activities of the 
oocyte, if secreted, would be expected to reduce the 
apparent yield of exogenous secretory products and 
thereby also affect the calculated half-life of their 
coding mRNAs. We therefore examined the presence 
of proteolytic activities secreted by Xenopus oocytes. 
To further estimate the effect of oocyte proteases 
on proteins secreted into the incubation medium, we 
measured the stability of proteins excreted from, or 
coincubated with Xenopus oocytes, both in the 
absence and presence of protease inhibitors. 
2. Materials and methods 
2.1. Xenopus oocytes 
Adult Xenopus Zaevis females were obtained from 
the South African Snake Farm (Fish Hoek, South 
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Africa). The toads were anaesthesized by cooling in 
ice, ovarian lobes were removed and individual 
oocytes were dissected and staged [ 11. The oocytes 
were incubated at 21’C in modified Barth medium 
[2] or under casein containing agar overlays [9]. 
Samples of incubation medium were removed and 
stored at -70°C until use. 
2.2. Gel analysis of proteolytic activities 
Samples of oocyte incubation medium were elec- 
trophoretically analyzed on 0.5 mm thick SDS-poly- 
acrylamide gels containing gelatin [lo]. Following 
electrophoresis, gels were washed in 2.5% Triton 
X-100 to remove SDS and incubated at 37°C. Gels 
were stained with Coomassie brilliant blue, and areas 
where gelatin was digested appeared as white trans- 
parent zones. 
2.3. Overlay analysis of individual oocytes 
Oocytes were laid in a 30 mm dish and covered 
with 0.8 ml agar-casein overlay [9], which contained 
3 parts of Barth medium, 2 parts of 2.5% purified 
agar [ 111 in Barth medium, 1 part of a 8% solution of 
commercial non-fat milk powder (Carnation) and, 
where indicated, also 20 pug/ml of human plasminogen 
[ 121. Following 15 h incubation at 21”C, oocytes 
were fixed with Dulbecco medium containing 10% 
pyridine and 2.5% glutaraldehyde and photographed. 
2.4. Determination of the protective effect of prote- 
ase inhibitors 
A mixture of commercially purified proteins 
(Sigma) was iodinated in the presence of chlormaine T 
as in [ 131. The mixture contained the following pro- 
teins (M,): bovine serum albumin (67 000); oval- 
bumin (45 000); chemotrypsinogen (24 300); fl-lacto- 
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globulin (18 400); and lysosyme (14 300). Aliquots 
of the mixture, containing 2 X lo6 cpm of 12SI-labeled 
proteins were added to 100 ~1 incubation media of 
groups of 10 oocytes, and coincubated with the 
oocytes in the presence and absence of protease inhib- 
itors. At 0, 20 and 40 h incubation, 10 ~1 samples 
were removed and the different proteins were electro- 
phoretically separated on a SDS-polyacrylamide gel 
together with non-labeled Mr markers [ 141. Gels were 
vacuum-dried and autoradiographed, and radiolabeled 
bands were cut out from the gel and counted in the 
y-counter. The inhibitors included were: trasylol 
(Sigma, aprotinin no. A-6012,0.23 TlU/ml final 
cont.); soybean trypsin inhibitor (Worthington, 
10 pg/ml); 6-aminocaproic acid (Aldrich Chemicals 
(Milwaukee WI) 2 X 10e3 M); leupeptin (5 X lo4 M); 
and antipain (5 X IO4 M). 
2.5. Determination of protein synthesis activity in 
Xenopus oocytes 
Oocytes were incubated in groups of 10 in 100 1.11 
Barth medium containing 15 PCi [35S]methionine 
(730 Ci/mmol, Amersham) and when indicated, also 
the protease inhibitors specified section in 2.4. Incor- 
poration of [ 3sS] methionine into trichloroacetic acid- 
insoluble protein was determined in [8], in 5 ~1 
aliquots of oocyte extracts after 0,20 and 40 h incu- 
bation at 21°C. No difference could be observed in 
the electrophoretic migration patterns of labeled pro- 
teins synthesized in oocytes incubated with or with- 
out protease inhibitors, as analyzed by autoradiogra- 
phy of polyacrylamide gels of these proteins. 
2.6. Analysis of interferon in medium of micro- 
injected oocytes 
Human fibroblast mRNA [ 15 ] was injected into sin- 
gle stage 6 selected Xenopus oocytes 50 ng/oocyte) 
and oocytes were incubated in groups of 10 in 100 ~.tl 
Barth medium, with or without lo4 M phenyl- 
methylsulfonylfluoride. Interferon titers were bio- 
assayed as in [ 151 following 20 h and 48 h incubation 
at 21°C. 
3. Results 
3.1. Heterogeneity of proteolytic activities in oocytes 
from different frogs 
As substrates to assay proteases of the oocytes we 
used fibrin [ 161, casein [9] and gelatin [lo]. Assays 
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were also performed in the presence of added plas- 
minogen, in order to detect plasminogen-activator- 
like proteases. The latter are highly specific proteases 
which convert the inactive zymogen plasminogen into 
the active non-specific endopeptidase plasmin, which 
can digest the 3 protein substrates employed [ 171. 
A survey of oocytes from 15 frogs revealed a 
prominent qualitative and quantitative heterogeneity 
of proteolytic activities, as demonstrated for 6 frogs 
in fig.1. The pattern of the electrophoretic mobility 
of active proteases ecreted by oocytes obtained from 
different frogs was determined by analysis on gelatin- 
containing polyacrylamide gels [lo]. For this analy- 
sis, groups of separated oocytes were incubated for 
20 h in Barth medium [2], and 5% of the incubation 
medium containing the secreted products were ana- 
lyzed. A representative xperiment of this type is 
shown in fig.1. Out of 6 different frogs, oocytes from 
1 frog did not show any activity, while oocytes from 
5 frogs expressed activities which migrated in the 
range corresponding to 20 000->80 000 Mr. In 
4 cases >l active species was seen. It is not known 
whether all of the different bands represent distinct 
molecular species, or are, at least in part, active deg- 
radation products derived from higher Mr forms. 
These findings clearly demonstrate the variability 
between oocytes from different frogs in the amount 
of the total apparent proteolytic activities and in the 
number and the electrophoretic migration patterns of 
the active bands. Identical results were obtained with 
gels containing plasminogen, indicating that the abil- 
ity to digest gelatin was in these cases plasminogen 
independent. Variability of a similar nature was 
Fig.1. Electrophoretic analysis of proteolytic activities 
secreted by Xenopus oocytes from different frogs. Groups of 
10 oocytes taken from 6 different frogs were incubated in 
100 ~1 Barth medium for 15 h at 21°C. Medium samples 
(6 ~1) of similar protein content were then electrophoreti- 
tally analyzed as in section 2. 
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obtained also with intracellular proteases tested in 
oocyte extract. In quantitative assays in which fibrin 
was utilized as a substrate [ 131 we observed differ- 
ences in the ratio between intracellular and secreted 
proteolytic activities of oocytes from different frogs 
(not shown). 
It should be noted that a lower variability and also 
a lower level of proteolytic activity was observed in 
oocytes obtained from frogs grown by the Nasco Co., 
as compared with the wild-caught South African 
frogs. However, the wild-caught frogs also displayed 
significantly higher levels of endogenous protein syn- 
thesis and of specific translation of exogenous micro- 
injected mRNA (submitted; unpublished). 
The activity of individual stage 6 oocytes [l] of 
the same frog was assayed in a casein overlay [9] with 
and without plasminogen (fig.2). The clear proteo- 
lytic zones surrounding the oocytes were absolutely 
plasminogen-dependent and exhibited a wide range of 
sizes, indicative of quantitative differences in the level 
of activities which are membrane bound and/or 
secreted by single oocytes. The dependence of the 
proteolysis on the addition of plasminogen to the 
overlay assay indicated that, in this experiment, it 
was due to a plasminogen-activator-like protease. 
Flasminogen-dependent ‘iibrinolysis was also observed 
Fig.2. Detection of plasminogendependent proteolytic activ- 
ity of single oocytes. Oocytes from a single frog were incu- 
bated under an agar-casein overlay [9] as in section 2, with 
and without human plasminogen [ 121 (20 pg/ml). Dark field 
photographs are presented. 
with oocytes from several frogs, and it was much 
higher with human plasminogen as a substrate as com- 
pared with chicken plasminogen (not shown). 
3.2. Extracellular proteolytic activities of staged 
oocy tes 
Xenopus oocytes serve as a unique experimental 
model for developmental studies related to gene 
expression [ 1 ,181. Several developmental processes 
have been shown to be modified under precisely con- 
trolled mechanisms during the maturation of Xeno- 
pus oocytes [ 19-221. To test whether or not the pro- 
teolytic activities of oocytes may be related to their 
developmental stage, oocytes from a single frog were 
separated into 3 groups containing oocytes in stages 
l-2,3-4, and 5-6 [ 11, and then were assayed for 
extracellular fibrinolytic activity ]13]. Plasminogen 
dependent fibrinolysis was found in all 3 stages, but 
with quantitative differences; whereas the amount of 
activity secreted/oocyte was 2-fold higher in stage 
5-6 as compared with stage l-2, the specific activ- 
ity, e.g., activity secreted/mg oocyte protein content, 
was 3-fold higher than in stage 1-2, and stage 34 
oocytes gave intermediate values. Plasminogen-inde- 
pendent fibrinolysis was also found in all 3 groups, 
and the amount secreted/oocyte was highest in stage 
l-2. Microinjection experiments are performed with 
either mature selected oocytes at stage 6 of their 
development [ 1 ] or with ovarian fragments, which 
contain connective tissue and immature oocytes in 
addition to mature oocytes [2,19]. Therefore, we 
suggest he use of selected oocytes rather than whole 
ovarian fragments for injection of mRNAs of secretory 
proteins, to achieve a fairly homogeneous system. 
Around the oocytes a layer of follicle cells appears 
during oocyte development [l] and is generally not 
removed before microinjection of mBNA [ 191. In the 
rat it has been shown that granulosa cells, which 
encapsulate the ovarian follicles and surround the rat 
oocytes, synthesize and secrete plasminogen activitor 
just prior to ovulation [23]. To determine whether 
follicle cells are the major contributors of proteolytic 
activities secreted by Xenopus oocytes, mature 
selected oocytes were manually defolliculated [20]. 
Intact and defolliculated oocytes, as well as the 
removed follicle cells, were incubated in Barth 
medium. Cell extracts and incubation medium were 
then analyzed for active proteolytic bands (fig.3). 
Activities of apparently similar M, were clearly 
detected in medium and extracts of both cell types, 
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Fig.3. Electrophoretic analysis of intracellular and secreted 
proteolytic activities of oocytes and follicle cells. Oocytes 
from a single frog were manually defolliculated [ 201. Intact 
oocytes [I], defolliculated oocytes [2] and separated follicle 
cells [ 31 were washed twice in Barth medium and incubated 
for 15 h at 21°C. Extract (A) and medium (B) samples repre- 
senting activity of 0.5 oocyte were then electrophoretically 
analyzed as in section 2. Similar patterns were observed when 
plasminogen was included in the gel [lo]. 
indicating that defolliculation procedures would not 
have prevented proteolysis in the incubation medium 
of Xenopus oocytes. 
3.3. Effect of protease inhibitors on proteins in 
oocyte medium 
It is suggested by our findings, that secretory pro- 
teins accumulated in oocyte incubation medium 
would be exposed to proteolytic degradation by the 
proteases ecreted into the medium, especially the 
plasminogen-independent proteases in fig.1. Partially 
purified human interferon incubated with viable 
Xenopus oocytes undergoes appreciable loss of activ- 
ity [8]. To minimize such proteolytic degradation we 
employed the mixture of protease inhibitors specified 
in fig.4, which has a wide range of action. The pres- 
ence of the tested inhibitors in the medium of viable 
oocytes did not affect protein synthesis in the 
oocytes, as shown in table 1. This mixture can thus 
be safely added to the incubation medium immedi- 
ately following microinjection of exogenous mRNA, 
and be kept there for X0 h. Several iodinated pro- 
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teins of different M,-values were coincubated with 
oocytes for 20 and 40 h, in the presence and absence 
of this mixture. A prominent decrease in the amounts 
of the different proteins occurred in the absence of 
the inhibitors and was partially prevented in their 
presence (fig.4). This experiment therefore indicated 
that protease inhibitors may increase the apparent 
yield of secretory translational products. 
The mixture of inhibitors utilized here was found 
to be toxic when tested in the bioassay for human 
c hrs 12 ‘0 
67 45 24 18 14 
1 
doleculor Weight 
Fig.4. Protection by protease inhibitors of labeled proteins 
coincubated with oocytes. A mixture of commercially puri. 
tied proteins (Sigma) was iodinated in the presence of chlor- 
maine T as in [ 131. The mixture contained the following pro- 
teins (M,): bovine serum albumin (67 000); ovalbumin 
(45 000); chemotrypsinogen (24 300); P-lactoglobulin 
(18 400); and lysosyme (14 300). Aliquots of the mixture, 
containing 2 X IO6 cpm of ‘*SI-labeled proteins were added 
to 100 r.11 incubation media of groups of 10 oocytes, and 
coincubated with the oocytes in the presence and absence of 
protease inhibitors. At 0, 20 and 40 h incubation, 10 ~1 sam- 
ples were removed and the different proteins were electro- 
phoretically separated on a SDS-polyacrylamide gel together 
with non-labeled Mr markers [ 141. Gels were vacuum-dried 
and autoradiographed, and radiolabeled bands were cut out 
from the gel and counted in the y-counter. Empty bars repre- 
sent values obtained without inhibitors. Hatched bars repre- 
sent values obtained in the presence of inhibitors. The inhibi- 
tors included were: trasylol (Sigma, aprotinin no. A-6012, 
0.23 TlU/ml final cont.); soybean trypsin inhibitor 
(Worthington, 10 pg/ml); 6-aminocaproic acid (Aldrich chem- 
ical (Milwaukee WI 2 x IO-’ M); leupeptin (5 X lo-’ M); and 
antipain (5 X 10d4 M). 
Volume 128, number 2 FEBS LETTERS June 1981 
Table 1 
Protein synthesis in oocytes incubated with protease 
inhibitors (PI) 
Incubation 
time (h) 
[ 35S]Methionine incorp. (cpm/oocyte) 
-PI +PI 
20 8.9 x 10’ 8.3 x 10’ 
40 3.1 x 105 3.1 x lo5 
Oocytes at stage 6 [l] were incubated in groups of 10 in the 
presence or absence of the mixture of protease inhibitors 
specified in section 2 and incorporation of [r’s] methionine 
into protein was determined on 5 ~1 samples of oocyte 
homogenates 
oocytes at all developmental stages, both by defolli- 
culated oocytes and by follicle cells. Exogenous pro- 
teins coincubated with viable oocytes undergo pro- 
teolytic degradation, which is reduced by the addi- 
tion of protease inhibitors to the medium. Similarly, 
the yield of active human interferon secreted from 
oocytes microinjected with fibroblast mRNA has also 
been improved when a protease inhibitor was added 
to the oocyte medium. 
interferon, which employs human cells in culture 
[ 151. It was therefore replaced by PMSF in experi- 
ments which involved the microinjection of inter- 
feron mRNA. PMSF increased the yield of biologi- 
cally active secreted interferon. Its effect was most 
prominent at 48 h post-injection, when a five-fold 
increase was obtained as compared with oocytes 
incubated without PMSF (table 2). 
We suggest he use of stage 6 selected single 
oocytes for microinjection experiments, and rou- 
tinely to add protease inhibitors to the incubation 
medium of Xenopus oocytes following microinjection 
of mRNAs coding for secretory proteins. Because of 
the heterogenous patterns of the proteolytic activities 
found in oocytes from different frogs, it is preferable 
to use a mixture of different inhibitors, which react 
with a wide range of proteases but do not affect pro- 
tein synthesis of the oocyte. When a protein product 
with a biological activity is pursued, inhibitors which 
do not affect the bioassay of the product should be 
selected. 
Discussion Acknowledgements 
Xenopus oocytes secrete variable levels of proteo- 
lytic activities of heterogeneous electrophoretic 
migration, which differ between oocytes from differ- 
ent frogs. Proteolytic activities are expressed by 
Table 2 
Protection of PMSF of active human interferon secreted by 
microinjected oocytes 
Medium Hours Human interferon (CPE unit/ml) 
Poly(A)+ RNA Control 
Barth 20 120 <lO 
Barth 48 20 <lO 
Barth + PMSF 20 160 <lO 
Barth + PMSF 48 100 20 
Oocytes were microinjected with human fibroblast mRNA 
[ 151. Control oocytes were injected with Barth medium [2]. 
Interferon activity, as measured by the interference with 
cytopathic effect (CPE units), was assayed by inhibition of 
growth of vesicular stomatitis virus (VW) on FSll human 
tibroblasts [ 151 
We are grateful to Dr Michel Revel for mRbJA and 
bioassay of human interferon, and to Dr Uriel Z. 
Littauer for critically reading the manuscript. We 
thank Mrs Rivka Zisling and MS Ofra Deutsch for their 
excellent technical ssistance. This investigation was 
supported by grants from the Israeli Commission for 
Basic Research (to H. S.) and from the United States- 
Israel Binational Science Foundation (BSF) Jerusalem 
(to R. M.). H. S. is a recipient of a Charles Revson 
Career Development Chair. 
References 
[l] Dumont, J. (1972) J. Morphol. 136,153-180. 
[2] Lane, C. D., Marbaix, G. and Gurdon, J. B. (1971) J. 
Mol. Biol. 61, 73-91. 
[ 31 Lane, C. D. and Knowland, J. (1975) in: The Biochem- 
istry of Animal Development (Wever, J. ed) vol. 3, 
pp. 145-181, Academic Press, New York. 
[4] Marbaix, G. and Huez, G. (1980) in: Transfer of Cell 
Constituents into Eukaryotic cells (Celis, J. E. et al. 
eds) pp. 347-381, Plenum, New York. 
[5] Colman, A. and Morser, J. (1979) Cell 17,517-526. 
309 
Volume 128, number 2 FEBS LETTERS June 1981 
[6] Zehavi-Willner, T. and Lane, C. (1977) Cell 11, 
683-693. 
[7] Sehgal, P. B., Soreq, H. and Tamm, I. (1978) Proc. Natl. 
Acad. Sci. USA 75,5030-5033. 
[ 8) Soreq, H., Sagar, A. D. and Sehgal, P. B. (1981) Proc. 
Natl. Acad. Sci. USA, in press. 
[9] Goldberg, A. R. (1974) Cell 2,95-102. 
[lo] Heussen, C. and Dowdle, E. B. (1980) Analyt. Biochem. 
102,196-202. 
[ 121 Deutsch, D. G. and Mertz, E. T. (1970) Science 170, 
1095-1096. 
[ 111 Dulbecco, R. and Vogt, M. (1954) J. Exp. Med. 99, 
167-199. 
[ 131 Soreq, H. and Miskin, R. (198 1) Brain Res. in press. 
[ 141 Soreq, H. and Littauer, U. Z. (197715. Biol. Chem. 
252,6885-6888. 
[ 151 Weissenbach, J., Chernajovsky, Y., Zeevi, M., Shulman, 
L., Soreq, H., Nir, U., Wallach, D., Perricaudet, M., 
Tiollais, P. and Revel, M. (1981) Proc. Natl. Acad. Sci. 
USA 77,7152-7156. 
[ 161 Unkeless, J. C., Tobia, A., Ossowski, L., Quigley, J. P., 
Rifkin, D. B. and Reich, E. (1973) J. Exp. Med. 137, 
85-111. 
[ 171 Christman, J. K., Silverstein, S. C. and Acs, G. (1980) 
in: Proteases in Mammalian Cells and Tissues (Barret, 
A. J. ed) pp. 91-149, Elsevier/North-Holland, 
Amsterdam, New York. 
[ 181 Davidson, E. H. (1976) Gene Activity in Early Develop- 
ment, 2nd edn, Academic Press, New York. 
[ 191 Gurdon, J. B. (1967) Proc. Natl. Acad. Sci. USA 58, 
545-552. 
[20] Benbow, R. M., Pestell, R. Q. W. and Ford, C. C. (1975) 
Dev. Biol. 43, 159-174. 
(211 Ruderman, J. W., Woodland, H. R. and Sturgess, E. A. 
(1979) Dev. Biol. 71,71-82. 
[22] Callen, J.-C., Tourte, M., Dennebouy, N. and Moulnov, 
J.-C. (1980) Cell 38, 13-18. 
[ 231 Beers, W. H., Strickland, S. and Reich, E. (1975) Cell 6, 
387-394. 
310 
